skip to main content

COV434

COV434

Catalogue No.

07071909

Cell Line Name

COV434

Cell Line Description

Human ovarian granulosa tumour cell line established from a solid primary tumour.

Access Cell line profile for this product.

Characteristics

Tissue of Origin

Ovary

DNA profile (STR Profile)

Amelogenin: X
CSF1PO: 10,11
D5S818: 10,11
D7S820: 8
D13S317: 8,12
D16S539: 9,12
TH01: 9.3
TPOX: 9,11
vWA: 16,18

Karyotype

Modal chromosome no. 47 (46 - 47)

Disease

Granulosa Tumour

Culture Conditions

Cell Type

Epithelial-like/Neuronal-like

Subculture Routine

Split confluent cultures 1:2 to 1:5 i.e. seeding at 2-4x10,000 cells/cm² using trypsin/EDTA; 5% CO₂; 37°C.

Culture Medium

DMEM + 2mM Glutamine + 10% Foetal Bovine Serum (FBS)

Growth Mode

Adherent

Additional Info

Depositor

Dr C E van der Minne, S H van der Burg & P I Schrier, Department of Clinical Oncology, Leiden University Medical Centre, Albinusdreef 2 K-I-P, 2333 ZA Leiden, Netherlands.

Country of Origin

Netherlands

Hazard Group (ACDP)

Hazard Group (ACDP) 2

Applications

References

van den Berg-Bakker CA, Hagemeijer A, Franken-Postma EM, Smit VT, Kuppen PJ, van Ravenswaay Claasen HH, Cornelisse CJ, Schrier PI 1993 Establishment and characterization of 7 ovarian carcinoma cell lines and one granulosa tumor cell line: growth features and cytogenetics. Int J Cancer. 53(4):613-20 PMID: 8436435.

Bibliography

Barretina J, et al., 2012 The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 483(7391):603-7. PMID: 22460905.

Available Formats

  • Frozen

If use of this culture results in a scientific publication, it should be cited in the publication as: COV434 (ECACC 07071909).

Unless specified otherwise, at ECACC we routinely handle all of our cell lines at containment level 2 in accordance with the ACDP guidelines (Advisory Committee on Dangerous Pathogens) (UK). All cell cultures have the potential to carry as yet unidentified adventitious agents. It is the responsibility of the end user to ensure that their facilities comply with biosafety regulations for their own country. ACDP Guidance: Biological agents: Managing the risks in laboratories and healthcare premises.

The Culture Collections represent deposits of cultures from world-wide sources. While every effort is made to ensure details distributed by Culture Collections are accurate, Culture Collections cannot be held responsible for any inaccuracies in the data supplied. References where quoted are mainly attributed to the establishment of the cell culture and not for any specific property of the cell line, therefore further references should be obtained regarding cell culture characteristics. Passage numbers where given act only as a guide and Culture Collections does not guarantee the passage number stated will be the passage number received by the customer.

Cultures supplied by Culture Collections are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.